Trial intelligence / Profile preview

Remimazolam vs midazolam for hemodynamic stability during anesthesia induction in elderly non-cardiac surgery

ChiCTR2100045491Phase 4Recruiting

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Remimazolam group with Midazolam group (2 arms). Primary endpoint: Incidence of patients with MAP < 60 mmHg or decrease >25% during induction. Started May 2021; status: recruiting.

02

Drugs

remimazolammidazolam

Beyond the preview

Go deeper on ChiCTR2100045491.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045491.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call